1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
1 of 4
FEATURED COMPANIES
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- MORE
Global Breast Biopsy Devices Market: About this market
The breast biopsy devices market analysis considers sales from biopsy needles and systems, biopsy image-guided systems, and other products. Our analysis report also considers finds the sales of breast biopsy devices in Asia, Europe, North America, and ROW. In 2018, the biopsy needles and systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the reduced technical complexities associated with biopsy needles and systems will play a significant role in the biopsy needles and systems segment to maintain its market position. Also, our global breast biopsy devices market report looks at factors such as the growing prevalence of breast cancer cases and an increasing number of products showcasing and approvals. However, high cost of breast biopsy, presence of alternative non-invasive procedures, and complications associated with breast biopsy and lack of trained professionals may hamper the growth of the breast biopsy devices industry over the forecast period.
Global Breast Biopsy Devices Market: Overview
Growing prevalence of breast cancer cases
Breast cancer is a deadly health condition and prevalent in women across the world. Even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. This is driving the need to create awareness and treat the patients after a proper analysis. Professionals are gathering a wide range of accumulative data and establishing facilities to encourage patients to undergo screening and diagnosis. This will boost the demand for breast biopsy procedures in various healthcare units. This growing prevalence of breast cancer cases will lead to the expansion of the global breast biopsy devices market at a CAGR of over 10% during the forecast period.
Paradigm shift toward the adoption of breast biopsy robot systems
There is an increase in the demand for technologically advanced breast biopsy devices comprising of robotic platforms, artificial intelligence, and surgical navigation systems. This is due to the growing demand need for minimally invasive procedures and accurate accurate and efficient surgical procedures. Vendors are focusing on improving the healthcare outcomes by developing technological solutions integrated with AI. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global breast biopsy devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices manufacturers, that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming future growth opportunities.
The breast biopsy devices market analysis considers sales from biopsy needles and systems, biopsy image-guided systems, and other products. Our analysis report also considers finds the sales of breast biopsy devices in Asia, Europe, North America, and ROW. In 2018, the biopsy needles and systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the reduced technical complexities associated with biopsy needles and systems will play a significant role in the biopsy needles and systems segment to maintain its market position. Also, our global breast biopsy devices market report looks at factors such as the growing prevalence of breast cancer cases and an increasing number of products showcasing and approvals. However, high cost of breast biopsy, presence of alternative non-invasive procedures, and complications associated with breast biopsy and lack of trained professionals may hamper the growth of the breast biopsy devices industry over the forecast period.
Global Breast Biopsy Devices Market: Overview
Growing prevalence of breast cancer cases
Breast cancer is a deadly health condition and prevalent in women across the world. Even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. This is driving the need to create awareness and treat the patients after a proper analysis. Professionals are gathering a wide range of accumulative data and establishing facilities to encourage patients to undergo screening and diagnosis. This will boost the demand for breast biopsy procedures in various healthcare units. This growing prevalence of breast cancer cases will lead to the expansion of the global breast biopsy devices market at a CAGR of over 10% during the forecast period.
Paradigm shift toward the adoption of breast biopsy robot systems
There is an increase in the demand for technologically advanced breast biopsy devices comprising of robotic platforms, artificial intelligence, and surgical navigation systems. This is due to the growing demand need for minimally invasive procedures and accurate accurate and efficient surgical procedures. Vendors are focusing on improving the healthcare outcomes by developing technological solutions integrated with AI. This development is expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global breast biopsy devices market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices manufacturers, that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming future growth opportunities.
Note: Product cover images may vary from those shown
2 of 4
FEATURED COMPANIES
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- MORE
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 09: MARKET SEGMENTATION BY END-USER
PART 12: DRIVERS AND CHALLENGES
PART 14: VENDOR LANDSCAPE
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Biopsy needles and systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Biopsy needles and systems - Year-over-year growth 2019-2023 (%)
Exhibit 22: Biopsy image-guided systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Biopsy image-guided systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Global breast biopsy devices market by modality (based on biopsy image-guided systems) in 2018
Exhibit 28: Customer landscape
Exhibit 29: Global breast biopsy devices market by end-user 2018
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Estimated cancer incidence in European countries 2018
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Reimbursement by Medicare for breast biopsy in the US
Exhibit 43: Market opportunity
Exhibit 44: Estimated incidence cases of cancer in European countries (2018)
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Business strategies and their market impact analysis
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Argon Medical Devices Inc. - Vendor overview
Exhibit 53: Argon Medical Devices Inc. - Business segments
Exhibit 54: Argon Medical Devices Inc. - Organizational developments
Exhibit 55: Argon Medical Devices Inc. - Key offerings
Exhibit 56: Argon Medical Devices Inc. - Key customers
Exhibit 57: Becton, Dickinson and Co. - Vendor overview
Exhibit 58: Becton, Dickinson and Co. - Product segments
Exhibit 59: Becton, Dickinson and Co. - Organizational developments
Exhibit 60: Becton, Dickinson and Co. - Geographic focus
Exhibit 61: Becton, Dickinson and Co. - Segment focus
Exhibit 62: Becton, Dickinson and Co. - Key offerings
Exhibit 63: Becton, Dickinson and Co. - Key customers
Exhibit 64: Carestream Health Inc. - Vendor overview
Exhibit 65: Carestream Health Inc. - Business segments
Exhibit 66: Carestream Health Inc. - Organizational developments
Exhibit 67: Carestream Health Inc. - Key offerings
Exhibit 68: Carestream Health Inc. - Key customers
Exhibit 69: Danaher Corp. - Vendor overview
Exhibit 70: Danaher Corp. - Business segments
Exhibit 71: Danaher Corp. - Organizational developments
Exhibit 72: Danaher Corp. - Geographic focus
Exhibit 73: Danaher Corp. - Segment focus
Exhibit 74: Danaher Corp. - Key offerings
Exhibit 75: Danaher Corp. - Key customers
Exhibit 76: FUJIFILM Holdings Corp. - Vendor overview
Exhibit 77: FUJIFILM Holdings Corp. - Business segments
Exhibit 78: FUJIFILM Holdings Corp. - Organizational developments
Exhibit 79: FUJIFILM Holdings Corp. - Geographic focus
Exhibit 80: FUJIFILM Holdings Corp. - Segment focus
Exhibit 81: FUJIFILM Holdings Corp. - Key offerings
Exhibit 82: FUJIFILM Holdings Corp. - Key customers
Exhibit 83: General Electric Co. - Vendor overview
Exhibit 84: General Electric Co. - Business segments
Exhibit 85: General Electric Co. - Organizational developments
Exhibit 86: General Electric Co. - Geographic focus
Exhibit 87: General Electric Co. - Segment focus
Exhibit 88: General Electric Co. - Key offerings
Exhibit 89: General Electric Co. - Key customers
Exhibit 90: Hologic Inc. - Vendor overview
Exhibit 91: Hologic Inc. - Business segments
Exhibit 92: Hologic Inc. - Organizational developments
Exhibit 93: Hologic Inc. - Geographic focus
Exhibit 94: Hologic Inc. - Segment focus
Exhibit 95: Hologic Inc. - Key offerings
Exhibit 96: Hologic Inc. - Key customers
Exhibit 97: Planmed Oy - Vendor overview
Exhibit 98: Planmed Oy - Product segments
Exhibit 99: Planmed Oy - Organizational developments
Exhibit 100: Planmed Oy - Key offerings
Exhibit 101: Planmed Oy - Key customers
Exhibit 102: Scion Medical Technologies LLC - Vendor overview
Exhibit 103: Scion Medical Technologies LLC - Product segments
Exhibit 104: Scion Medical Technologies LLC - Key offerings
Exhibit 105: Scion Medical Technologies LLC - Key customers
Exhibit 106: Siemens Healthineers AG - Vendor overview
Exhibit 107: Siemens Healthineers AG - Business segments
Exhibit 108: Siemens Healthineers AG - Organizational developments
Exhibit 109: Siemens Healthineers AG - Geographic focus
Exhibit 110: Siemens Healthineers AG - Segment focus
Exhibit 111: Siemens Healthineers AG - Key offerings
Exhibit 112: Siemens Healthineers AG - Key customers
Exhibit 113: Validation techniques employed for market sizing
Exhibit 114: Definition of market positioning of vendors
PART 02: SCOPE OF THE REPORT
- Preface
- Currency conversion rates for US$
- Market ecosystem
- Market characteristics
- Market segmentation analysis
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
- Market segmentation by product
- Comparison by product
- Biopsy needles and systems - Market size and forecast 2018-2023
- Biopsy image-guided systems - Market size and forecast 2018-2023
- Others - Market size and forecast 2018-2023
- Market opportunity by product
- Stereotactic X-ray guided breast biopsy
- Ultrasound-guided breast biopsy
- MRI-guided breast biopsy
PART 09: MARKET SEGMENTATION BY END-USER
- Hospitals
- ASCs
- Breast cancer specialty centers and clinics
- Others
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 12: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 14: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
- Vendors covered
- Vendor classification
- Market positioning of vendor
- Argon Medical Devices, Inc.
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- Planmed Oy
- Scion Medical Technologies LLC
- Siemens Healthineers AG
- Research methodology
- List of abbreviations
- Definition of market positioning of vendors
Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Biopsy needles and systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Biopsy needles and systems - Year-over-year growth 2019-2023 (%)
Exhibit 22: Biopsy image-guided systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Biopsy image-guided systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others - Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Global breast biopsy devices market by modality (based on biopsy image-guided systems) in 2018
Exhibit 28: Customer landscape
Exhibit 29: Global breast biopsy devices market by end-user 2018
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
Exhibit 34: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Estimated cancer incidence in European countries 2018
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Reimbursement by Medicare for breast biopsy in the US
Exhibit 43: Market opportunity
Exhibit 44: Estimated incidence cases of cancer in European countries (2018)
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Business strategies and their market impact analysis
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Argon Medical Devices Inc. - Vendor overview
Exhibit 53: Argon Medical Devices Inc. - Business segments
Exhibit 54: Argon Medical Devices Inc. - Organizational developments
Exhibit 55: Argon Medical Devices Inc. - Key offerings
Exhibit 56: Argon Medical Devices Inc. - Key customers
Exhibit 57: Becton, Dickinson and Co. - Vendor overview
Exhibit 58: Becton, Dickinson and Co. - Product segments
Exhibit 59: Becton, Dickinson and Co. - Organizational developments
Exhibit 60: Becton, Dickinson and Co. - Geographic focus
Exhibit 61: Becton, Dickinson and Co. - Segment focus
Exhibit 62: Becton, Dickinson and Co. - Key offerings
Exhibit 63: Becton, Dickinson and Co. - Key customers
Exhibit 64: Carestream Health Inc. - Vendor overview
Exhibit 65: Carestream Health Inc. - Business segments
Exhibit 66: Carestream Health Inc. - Organizational developments
Exhibit 67: Carestream Health Inc. - Key offerings
Exhibit 68: Carestream Health Inc. - Key customers
Exhibit 69: Danaher Corp. - Vendor overview
Exhibit 70: Danaher Corp. - Business segments
Exhibit 71: Danaher Corp. - Organizational developments
Exhibit 72: Danaher Corp. - Geographic focus
Exhibit 73: Danaher Corp. - Segment focus
Exhibit 74: Danaher Corp. - Key offerings
Exhibit 75: Danaher Corp. - Key customers
Exhibit 76: FUJIFILM Holdings Corp. - Vendor overview
Exhibit 77: FUJIFILM Holdings Corp. - Business segments
Exhibit 78: FUJIFILM Holdings Corp. - Organizational developments
Exhibit 79: FUJIFILM Holdings Corp. - Geographic focus
Exhibit 80: FUJIFILM Holdings Corp. - Segment focus
Exhibit 81: FUJIFILM Holdings Corp. - Key offerings
Exhibit 82: FUJIFILM Holdings Corp. - Key customers
Exhibit 83: General Electric Co. - Vendor overview
Exhibit 84: General Electric Co. - Business segments
Exhibit 85: General Electric Co. - Organizational developments
Exhibit 86: General Electric Co. - Geographic focus
Exhibit 87: General Electric Co. - Segment focus
Exhibit 88: General Electric Co. - Key offerings
Exhibit 89: General Electric Co. - Key customers
Exhibit 90: Hologic Inc. - Vendor overview
Exhibit 91: Hologic Inc. - Business segments
Exhibit 92: Hologic Inc. - Organizational developments
Exhibit 93: Hologic Inc. - Geographic focus
Exhibit 94: Hologic Inc. - Segment focus
Exhibit 95: Hologic Inc. - Key offerings
Exhibit 96: Hologic Inc. - Key customers
Exhibit 97: Planmed Oy - Vendor overview
Exhibit 98: Planmed Oy - Product segments
Exhibit 99: Planmed Oy - Organizational developments
Exhibit 100: Planmed Oy - Key offerings
Exhibit 101: Planmed Oy - Key customers
Exhibit 102: Scion Medical Technologies LLC - Vendor overview
Exhibit 103: Scion Medical Technologies LLC - Product segments
Exhibit 104: Scion Medical Technologies LLC - Key offerings
Exhibit 105: Scion Medical Technologies LLC - Key customers
Exhibit 106: Siemens Healthineers AG - Vendor overview
Exhibit 107: Siemens Healthineers AG - Business segments
Exhibit 108: Siemens Healthineers AG - Organizational developments
Exhibit 109: Siemens Healthineers AG - Geographic focus
Exhibit 110: Siemens Healthineers AG - Segment focus
Exhibit 111: Siemens Healthineers AG - Key offerings
Exhibit 112: Siemens Healthineers AG - Key customers
Exhibit 113: Validation techniques employed for market sizing
Exhibit 114: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4
LOADING...
4 of 4
FEATURED COMPANIES
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- MORE
The following companies are recognised as the key players in the global breast biopsy devices market: Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the paradigm shift toward adoption of breast biopsy robot systems.”
According to the report, one of the major drivers for this market is the growing prevalence of breast cancer cases.
Further, the report states that one of the major factors hindering the growth of this market is the complications associated with breast biopsy and lack of trained professionals.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the paradigm shift toward adoption of breast biopsy robot systems.”
According to the report, one of the major drivers for this market is the growing prevalence of breast cancer cases.
Further, the report states that one of the major factors hindering the growth of this market is the complications associated with breast biopsy and lack of trained professionals.
The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
- Argon Medical Devices, Inc.
- Becton, Dickinson and Co.
- Carestream Health Inc.
- Danaher Corp.
- FUJIFILM Holdings Corp.
- General Electric Co.
- Hologic Inc.
- Planmed Oy
- Scion Medical Technologies LLC
- Siemens Healthineers AG
Note: Product cover images may vary from those shown
